Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records
Pharmacology, Toxicology and Pharmaceutical Science
1
6%
Medicine and Dentistry
1
6%
Other
0
0%
Unknown
10
56%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 315. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2026.
All research outputs
#136,535
of 34,355,701 outputs
Outputs from Neuropsychopharmacology
#63
of 6,311 outputs
Outputs of similar age
#1,837
of 417,404 outputs
Outputs of similar age from Neuropsychopharmacology
#1
of 47 outputs
Altmetric has tracked 34,355,701 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,311 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 417,404 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.
